THE DECISION-POINT APPROACH FOR SYSTEMATIC CARCINOGEN TESTING

[1] AMES BN, 1980, MICROSOMES DRUG OXID, V2, P1025

[2] BROOKES P, 1980, BRIT MED B, V36

[3] COHEN SM, 1979, CANCER RES, V39, P1207

[4] Coon M, 1980, MICROSOMES DRUG OXID, V1

[5] COON MJ, 1980, MICROSOMES DRUG OXID, V2

[6] Ehrenberg L., 1973, EVALUATION GENETIC R, P15

[7] EMMELOT P, 1979, ENV CARCINOGENESIS O

[8] FRAUMENI JF, 1975, PERSONS HIGH RISK CA

[9] GRIFFIN AC, 1979, CARCINOGENS IDENTIFI

[10] GROVER PL, 1979, CHEM CARCINOGENS DNA, V2

[1] AMES BN, 1980, MICROSOMES DRUG OXID, V2, P1025

[2] BROOKES P, 1980, BRIT MED B, V36

[3] COHEN SM, 1979, CANCER RES, V39, P1207

[4] Coon M, 1980, MICROSOMES DRUG OXID, V1

[5] COON MJ, 1980, MICROSOMES DRUG OXID, V2

[6] Ehrenberg L., 1973, EVALUATION GENETIC R, P15

[7] EMMELOT P, 1979, ENV CARCINOGENESIS O

[8] FRAUMENI JF, 1975, PERSONS HIGH RISK CA

[9] GRIFFIN AC, 1979, CARCINOGENS IDENTIFI

[10] GROVER PL, 1979, CHEM CARCINOGENS DNA, V2